Lanoconazole

Drug Profile

Lanoconazole

Alternative Names: Astat; Latoconazole; M-1100; M-110101; NND-318; TJN-318

Latest Information Update: 02 Dec 2016

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Nihon Nohyaku
  • Developer Maruho; Nihon Nohyaku; Tsumura
  • Class Antifungals; Azoles; Imidazoles; Small molecules
  • Mechanism of Action Sterol demethylase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Candidiasis; Tinea; Tinea cruris; Tinea pedis
  • Phase II Seborrhoeic dermatitis

Most Recent Events

  • 23 May 2016 Maruho completes a phase trial in Healthy volunteers in Japan (UMIN000016466)
  • 26 Apr 2006 Registered for Tinea cruris in Japan (unspecified route)
  • 26 Apr 2006 Registered for Tinea pedis in Japan (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top